ABBV is trading at $228.10, up 5.4% versus the comparison close of $216.49 during regular trading. This is a price-movement alert; no separate company-specific catalyst was searched for this follow-up.
🟢 AbbVie Inc. extends move to 5.4% up
AbbVie Inc.
Related News
ABBV
🟢 ABBV surges 6.1% in pre-market on continued momentum from $10.9 billion Apogee Therapeutics acquisition
ABBV
AbbVie to acquire Apogee Therapeutics for $10.9B to expand immunology pipeline
ABBV
AbbVie Nears $10.9 Billion Apogee Deal, Strengthening Immunology Pipeline
ABBV
AbbVie Unveils Venclexta and Epcoritamab Data, Bolstering Oncology Market Position
ABBV